Back to Archived Journals » Core Evidence » Volume 6

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Total article views   HTML views PDF downloads Totals
16,940 Dovepress* 11,886+ 4,744 16,630
PubMed Central* 5,054 1,453 6,507
Totals 16,940 6,197 23,137
*Since 4 April 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar